The statistical games behind "off-label" prescription drug use.

How to fix health policy.
Dec. 21 2009 12:28 PM

Cooking the Books

The statistical games behind "off-label" prescription drug use.

(Continued from Page 1)

Without greater oversight from medical journals, the public must rely on whistle-blowers to come forward, as with Neurontin (such folks collect a hefty bounty from damage awards). But it would certainly be better for our collective health if clinical studies were kept honest from the beginning.

Become a fan of Slate on Facebook. Follow us on Twitter.

Darshak Sanghavi, a pediatric cardiologist, is a fellow of the Brookings Institution and Slate’s health care columnist. Follow him on Twitter.